Print

V24P1

A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults

Trial Details:

I Completed
Chiron
HIV p24/MF59 Vaccine
HIV p24/MF59 Vaccine Protein
USA 40
NCT00002204
http://clinicaltrials.gov/ct2/show/NCT00002204